Idiopathic Pulmonary Fibrosis Registry for Future Studies
| Status: | Completed |
|---|---|
| Conditions: | Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | December 2008 |
| End Date: | January 2015 |
| Contact: | Janice E Drake, CRTT |
| Email: | janice.drake@osumc.edu |
| Phone: | 614-688-2287 |
Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis
To establish a registry of patients for future studies of Inflammation in Interstitial Lung
Disease/Idiopathic Pulmonary Fibrosis.
Disease/Idiopathic Pulmonary Fibrosis.
To establish a framework in which biologic samples and physiologic measures from patients
with IPF can be longitudinally collected and evaluated. Having a bank of samples that are
correlated with physiologic measures that follow patients through their course will allow
the following proposed studies as well as future investigations to be efficiently carried
out.
with IPF can be longitudinally collected and evaluated. Having a bank of samples that are
correlated with physiologic measures that follow patients through their course will allow
the following proposed studies as well as future investigations to be efficiently carried
out.
Inclusion Criteria:
- any patient referred to the Interstitial Lund Disease clinic who is undergoing
evaluation and or treatment for a new diagnosis of ILD. This can include patients
referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP),
sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia,
drug-induced, or other idiopathic ILDs.
Exclusion Criteria:
- pregnancy
- inability to follow study requirements
We found this trial at
1
site
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
Click here to add this to my saved trials
